LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 58.15 | 27.76 | 8271 | 5906 | 1.4003 | 1.0890 | MN20160318_Q01 | J19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 58.15 | 27.76 | 7385 | 5906 | 1.2503 | 1.0586 | MN20160318_Q01 | N10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 58.15 | 27.76 | 7543 | 5906 | 1.2770 | 1.0643 | MN20160318_Q01 | N10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 58.15 | 27.76 | 362 | 5906 | 0.0613 | 0.3939 | MN20160318_Q01 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 58.15 | 27.76 | 6857 | 5906 | 1.1609 | 1.0390 | MN20160318_Q01 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 59.85 | 27.76 | 574 | 6062 | 0.0947 | 0.4767 | MN20160318_Q01 | G22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 59.85 | 27.76 | 6401 | 6062 | 1.0558 | 1.0140 | MN20160318_Q01 | G22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 59.85 | 27.76 | 1048 | 6062 | 0.1729 | 0.5956 | MN20160318_Q01 | J19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 59.85 | 27.76 | 8634 | 6062 | 1.4241 | 1.0931 | MN20160318_Q01 | J19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 59.85 | 27.76 | 7667 | 6062 | 1.2646 | 1.0613 | MN20160318_Q01 | N10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 59.85 | 27.76 | 7789 | 6062 | 1.2848 | 1.0655 | MN20160318_Q01 | N10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 59.85 | 27.76 | 274 | 6062 | 0.0452 | 0.3426 | MN20160318_Q01 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 59.85 | 27.76 | 7109 | 6062 | 1.1726 | 1.0414 | MN20160318_Q01 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 61.56 | 27.76 | 549 | 6217 | 0.0883 | 0.4656 | MN20160318_Q01 | G22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 61.56 | 27.76 | 6699 | 6217 | 1.0775 | 1.0192 | MN20160318_Q01 | G22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 61.56 | 27.76 | 990 | 6217 | 0.1592 | 0.5806 | MN20160318_Q01 | J19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 61.56 | 27.76 | 9096 | 6217 | 1.4630 | 1.0999 | MN20160318_Q01 | J19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 61.56 | 27.76 | 8009 | 6217 | 1.2882 | 1.0659 | MN20160318_Q01 | N10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 61.56 | 27.76 | 8218 | 6217 | 1.3218 | 1.0728 | MN20160318_Q01 | N10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 61.56 | 27.76 | 282 | 6217 | 0.0454 | 0.3458 | MN20160318_Q01 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 61.56 | 27.76 | 7445 | 6217 | 1.1975 | 1.0467 | MN20160318_Q01 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 63.26 | 27.76 | 574 | 6465 | 0.0888 | 0.4699 | MN20160318_Q01 | G22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 63.26 | 27.76 | 6974 | 6465 | 1.0786 | 1.0193 | MN20160318_Q01 | G22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 63.26 | 27.76 | 1053 | 6465 | 0.1629 | 0.5878 | MN20160318_Q01 | J19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 63.26 | 27.76 | 9459 | 6465 | 1.4630 | 1.0991 | MN20160318_Q01 | J19 |